Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11359009 Anti-myostatin antibodies and methods of use

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 22, 2016
Date of Patent
June 14, 2022
Patent Application Number
16065192
Patent Citations
‌
US Patent 10000560 Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
0
‌
US Patent 10111953 Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
‌
US Patent 10472623 Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
‌
US Patent 10253100 Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance
‌
US Patent 11046784 Methods for controlling blood pharmacokinetics of antibodies
‌
US Patent 10919953 FcgammaRIIB-specific Fc region variant
‌
US Patent 10519229 Nucleic acids encoding IL-8 antibodies
Patent Citations Received
‌
US Patent 12122840 Method of modifying isoelectric point of antibody via amino acid substitution in CDR
0
‌
US Patent 11891434 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
0
‌
US Patent 12116414 Method of modifying isoelectric point of antibody via amino acid substitution in CDR
0
Patent Inventor Names
Yoshinao Ruike
0
Taichi Kuramochi
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11359009
Patent Primary Examiner
‌
Brian Gangle

Find more entities like US Patent 11359009 Anti-myostatin antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo